Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel. (Record no. 16152482)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02163 a2200553 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515020830.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200610s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0344-5704 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/s00280-006-0214-9 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Chang, Chih-Chuan |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20061016 |
245 00 - TITLE STATEMENT | |
Title | Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Cancer chemotherapy and pharmacology |
Date of publication, distribution, etc. | Nov 2006 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 640-53 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | ATP Binding Cassette Transporter, Subfamily B, Member 1 |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents, Phytogenic |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Blotting, Western |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Breast Neoplasms |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dose-Response Relationship, Drug |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Doxorubicin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Multiple |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Neoplasm |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Expression |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Masoprocol |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, Nude |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Monosaccharides |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Paclitaxel |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | RNA, Messenger |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Reverse Transcriptase Polymerase Chain Reaction |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
General subdivision | methods |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Liang, Yu-Chuan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Klutz, Athena |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hsu, Chuan-I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lin, Chien-Fu |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mold, David E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chou, Ting-Chao |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lee, Yuan Chuan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Huang, Ru Chih C |
773 0# - HOST ITEM ENTRY | |
Title | Cancer chemotherapy and pharmacology |
Related parts | vol. 58 |
-- | no. 5 |
-- | p. 640-53 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/s00280-006-0214-9">https://doi.org/10.1007/s00280-006-0214-9</a> |
Public note | Available from publisher's website |
No items available.